Red cell distribution width (RDW) as a predictor of long-term mortality in patients undergoing percutaneous coronary intervention

Thrombosis and Haemostasis

Volumn 102, Issue 3, 2009, Pages 581-587

  Poludasu, Shyam ^a   Marmur, Jonathan D ^a   Weedon, Jeremy ^a   Khan, Waqas ^a   Cavusoglu, Erdal ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

Mortality; Percutaneous coronary intervention; Red cell distribution width (RDW)

Indexed keywords

FIBRINOGEN RECEPTOR ANTAGONIST; HEMOGLOBIN;

ADULT; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ERYTHROCYTE VOLUME; FEMALE; FOLLOW UP; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CELL SIZE; ERYTHROCYTES; FEMALE; HEART DISEASES; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 70449347211     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH09-02-0127     Document Type: Article

References (23)

1. Roberts GT, El Badawi SB. Red blood cell distribution width index in some hematologic diseases. Am J Clin Pathol 1985; 8): 222-226.
2. Evans TC, Jehle D. The red blood cell distribution width. J Emerg Med 1991; 9 (Suppl 1): 71-74.
3. Looker AC, Gunter EW, Johnson CL: Methods to assess iron status in various NHANES surveys. Nutr Rev 1995; 53: 246-254.
4. Van hove L, Schisano T, Brace L. Anemia diagnosis, classification, and monitoring using Cell-Dyn Technology reviewed for the new millennium. Lab Hematol 2000; 6: 93-108.
5. Tefferi A, Hanson CA, Inwards DJ. How to interpret and pursue an abnormal complete blood cell count in adults. Mayo Clin Proc 2005; 80: 923-936. (Pubitemid 40911466)
6. Felker GM, Allen LA, Pocock SJ, et al.: Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. J Am Coll Cardiol 2007; 50: 40-47.
7. Tonelli M, Sacks F, Arnold M, et al. Relation Between Red Blood Cell Distribution Width and Cardiovascular Event Rate in People With Coronary Disease. Circulation 2008; 117: 163-168.
8. Cavusoglu E, Chopra V, Gupta A, et al. Relation between red blood cell distribution width (RDW) and all-cause mortality at two years in an unselected population referred for coronary angiography. Int J Cardiol 2009; Epub ahead of print.
9. Perlstein TS, Weuve J, Pfeffer MA, et al. Red blood cell distribution width and mortality risk in a community-based prospective cohort. Arch Intern Med 2009; 169: 588-594.
10. Lippi G, Filippozzi L, Montagnana M, et al. Short Communication: Clinical usefulness of measuring red blood cell distribution width on admission in patients with acute coronary syndromes. Clin Chem Lab Med 2009; Epub ahead of print.
11. Marmur JD, Poludasu S, Agarwal A, et al. High-dose tirofiban administered as bolus-only during percutaneous coronary intervention. J Invasive Cardiol 2008; 20: 53-58. (Pubitemid 351271441)
12. Marmur JD, Poludasu S, Agarwal A, et al.: Bolus- only platelet glycoprotein IIb-IIIa inhibition during percutaneous coronary intervention. J Invasive Cardiol 2006; 18: 521-526. (Pubitemid 44704515)
13. Alpert JS, Thygesen K, Antman E, et al. Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000; 36: 959-969. (Pubitemid 30681627)
14. Curb JD, Ford CE, Pressel S, et al. Ascertainment of vital status through the National Death Index and the Social Security Administration. Am J Epidemiol 1985; 121: 754-766. (Pubitemid 15056510)
15. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction - 2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). Circulation 2002; 106: 1893-1900.
16. Lin DY, Wei LJ, Ying Z. Checking the Cox model with cumulative sums of Martingale-based residuals. Biometrika 1993; 80: 557-572.
17. Lippi G, Targher G, Montagnana M, et al. Relationship between red blood cell distribution width and kidney function tests in a large cohort of unselected outpatients. Scand J Clin Lab Invest 2008; 68: 745-748.
18. Reinecke H, Trey T, Wellmann J, et al.: Haemoglobin- related mortality in patients undergoing percutaneous coronary interventions. Eur Heart J 2003; 24: 2142-2150. (Pubitemid 37486534)
19. McKechnie RS, Smith D, Montoye C, et al. Prognostic implication of anemia on in-hospital outcomes after percutaneous coronary intervention. Circulation 2004; 110: 271-277. (Pubitemid 38955496)
20. Nikolsky E, Aymong ED, Halkin A, et al. Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial. J Am Coll Cardiol 2004; 44: 547-553. (Pubitemid 39078177)
21. Levey AS, Coresh J, Balk E, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003; 139: 137-147. (Pubitemid 38129105)
22. Gottlieb SS: Dead is dead - artificial definitions are no substitute. Lancet 1997; 349: 662-663.
23. Lauer MS, Blackstone EH, Young JB, et al. Cause of death in clinical research: time for a reassessment? J Am Coll Cardiol 1999; 34: 618-620.